PL
PL · PL · PL-100342499
Abacavir + Lamivudine Accord
ATC J05AR02
Last synced from URPL (Poland) on
Identification
ManufacturerAccord Healthcare Polska Sp. z o.o.
CountryPL (PL)
ATC codeJ05AR02
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin05909991302498
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "600 mg + 300 mg",
"packaging": "05909991302498 ¦ Rpz ¦ 118742\n30 tabl.",
"substance": "Abacaviri hydrochloridum 600,00 mg + Lamivudinum 300,00 mg",
"common_name": "Abacavirum + Lamivudinum",
"pl_product_id": "100342499",
"pozwolenie_nr": "23541",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}Related drugs
Other records sharing ATC code J05AR02.
- PLAbacavir + Lamivudine AccordDelfarma Sp. z o.o.
- PLAbacavir + Lamivudine SandozSandoz GmbH
- 🇨🇭Abacavir Lamivudin SandozSandoz Pharmaceuticals AG
- 🇨🇭Abacavir-Lamivudin-MephaMepha Pharma AG
- DKAbacavir/Lamivudin "Medical Valley"Medical Valley Invest AB
- DKAbacavir/Lamivudin "Mylan"Mylan AB
- FIAbacavir/Lamivudin MylanMylan AB
- FIAbacavir/Lamivudin MylanParanova Oy
Access this data programmatically
Query Abacavir + Lamivudine Accord and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.